Class of Stock [Axis]
Series E Preferred Stock [Member]
Series F Preferred Stock [Member]
Series A Preferred Stock [Member]
Series C-1 Preferred Stock [Member]
Series C-2 Preferred Stock [Member]
Series D-1 Preferred Stock [Member]
Series D-2 Preferred Stock [Member]
Equity Components [Axis]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Preferred Stock Series C-1 [Member]
Preferred Stock Series C-2 [Member]
Preferred Stock Series D-1 [Member]
Preferred Stock Series D-2 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Asset Purchase Agreement [Member]
Business Acquisition [Axis]
Avant [Member]
Legal Entity [Axis]
OncBio Mune Sub Inc [Member]
Title of Individual [Axis]
Various Investors [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Customer [Axis]
Customer One [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Customer Two [Member]
Customer Three [Member]
Accounts Receivable [Member]
Deferred Revenue [Member]
Customer Four [Member]
Antidilutive Securities [Axis]
Warrant [Member]
Convertible Debt Securities [Member]
Amarantus BioScience Holdings, Inc. [Member]
Long-Lived Tangible Asset [Axis]
Laboratory Equipment [Member]
Furniture and Fixtures [Member]
Leasehold Improvements [Member]
Computer Equipment [Member]
Investors [Member]
Debt Instrument [Axis]
Convertible Note [Member]
Securities Purchase Agreement [Member]
Scenario [Axis]
First Tranche [Member]
Second Tranche [Member]
Third Tranche [Member]
Investor [Member]
Note One [Member]
Warrant One [Member]
Note Two [Member]
Warrant Two [Member]
Note Three [Member]
Warrant Three [Member]
First Investors [Member]
Fisrt Investor [Member]
First Investor [Member]
First Investors [Member]
Second Investor [Member]
Second Investors [Member]
Third Investor [Member]
Second and Third Investor [Member]
Fourth Investor [Member]
Fifth Investor [Member]
Related Party [Axis]
Jeffrey Busch [Member]
Promissory Note Agreement [Member]
Note Agreement [Member]
First Lessor [Member]
Financing Agreement [Member]
Second Lessor [Member]
Third Lessor [Member]
Fourth Lessor [Member]
Fifth Lessor [Member]
Lease Agreement [Member]
First Year [Member]
Second year [Member]
Third Year [Member]
Fourth Year [Member]
Fifth Year [Member]
Cumulative Effect, Period of Adoption [Axis]
Accounting Standards Update 2016-02 Cumulative Effect, Period of Adoption [Member]
Lease Amendment [Member]
Award Type [Axis]
Mr. Kucharchuk [Member]
Related Party [Member]
Fourth Investors [Member]
Board of Directors [Member]
Two Consultants [Member]
Subscription Agreement [Member]
Plan Name [Axis]
2011 Stock Option Plan [Member]
Derivative Instrument [Axis]
Equity Option [Member]
First November 2021 [Member]
Second November 2021 [Member]
Third November 2021 [Member]
First January 2022 [Member]
Second January 2022 [Member]
Dr. Michael Ruxin [Member]
Ruxin Employment Agreement [Member]
2020 Equity Incentive Plan [Member]
Share-Based Payment Arrangement, Option [Member]
Busch Employment Agreement [Member].
Restricted Stock Units (RSUs) [Member]
Thomas E Chilcott [Member]
Offer Letter [Member]
Thomas E Chilcott Three [Member]
Consultant [Member]
Scientific Advisory Board Service Agreement [Member]
Pathology Advisory Board Service Agreement [Member]
Consulting Agreement [Member]
Kucharchuk [Member]
Exclusive License Agreement [Member]
George Mason University [Member]
Sublicense Royalty [Member]
License Agreement [Member]
National Institutes of Health [Member]
Employee Incentive Stock Options [Member]
Settlement of Accounts Payable [Member]
Two Notes Payable [Member]
Conversion of Series C-1 Preferred Stock [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Note [Member]
Board of Directors Chairman [Member]
Related Party Transaction [Axis]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement [Table]
Statement [Line Items]
ASSETS
CURRENT ASSETS:
Cash
Accounts receivable
Other receivable (related party $35,594 in 2022 and $21,711 in 2021)
Prepaid expenses and other current assets
Marketable securities
Laboratory supplies
Total Current Assets
OTHER ASSETS:
Property and equipment, net
Finance right-of-use assets, net
Operating right-of-use asset, net
Security deposits
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
CURRENT LIABILITIES:
Accounts payable
Accounts payable - related party
Accrued liabilities
Accrued liabilities - related party
Accrued compensation
Accrued director compensation
Contract liabilities
Notes payable - related party
Notes payable - current
Financing lease liability - current
Operating lease liability - current
Insurance payable
Subscriptions payable
Contingent liabilities
Total Current Liabilities
LONG-TERM LIABILITIES:
Financing lease liability
Operating lease liability
Convertible notes - related party, net of discount
Convertible notes, net of discount
Total Liabilities
Commitments and Contingencies (Note 10)
Temporary equity value
STOCKHOLDERS’ DEFICIT:
Preferred stock value
Common stock: $0.0001 par value, 12,000,000,000 shares authorized; 6,026,499,919 and 5,124,164,690 issued and outstanding at March 31, 2022 and September 30, 2021, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Deficit
Total Liabilities and Stockholders’ Deficit
Other receivable related party
Temporary equity, par or stated value per share
Temporary equity, shares authorized
Temporary equity, shares issued
Temporary equity, shares outstanding
Temporary equity, liquidation preference
Preferred stock, par or stated value per share
Preferred stock shares authorized
Preferred stock shares issued
Preferred stock shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
REVENUES, NET
COST OF REVENUE
GROSS PROFIT
OPERATING EXPENSES:
Professional fees
Compensation expense
Licensing fees
General and administrative expenses
Total Operating Expenses
LOSS FROM OPERATIONS
OTHER INCOME (EXPENSE):
Interest expense, net
Gain on debt extinguishment, net
Unrealized (loss) gain on marketable securities
Unrealized loss on exchange rate
Total Other Income (Loss), net
NET LOSS
Preferred stock dividend
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
NET LOSS PER COMMON SHARE:
Basic and Diluted
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic and Diluted
Beginning balance, value
Beginning balance, shares
Relative fair value of warrants issued in connection with convertible notes - related party recorded as debt discount
Relative fair value of warrants issued in connection with convertible notes recorded as debt discount
Series E preferred stock dividend
Series F preferred stock dividend
Correction for rounding error
Correction for rounding error shares
Net loss
Issuance of common stock in connection with conversion of Series C-1 preferred stock
Issuance of common stock in connection with conversion of series C-1 preferred stock shares
Issuance of common stock in connection with conversion of Series C-2 preferred stock
Issuance of common stock in connection with conversion of series C-2 preferred stock shares
Issuance of common stock in connection with settlement of accounts payable
Issuance of common stock in connection with settlement of accounts payable shares
Issuance of common stock in connection with subscriptions payable
Issuance of common stock in connection with subscriptions payable shares
Relative fair value of additional warrants issued in connection with modification of convertible notes - related party recorded as debt discount
Relative fair value of additional warrants issued in connection with modification of convertible notes recorded as debt discount
Adjustment related to Series A preferred prior period redemption payment
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS USED IN OPERATING ACTIVITIES
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation on property and equipment and finance ROU assets
Non-cash lease cost
Amortization of debt discount
Gain on debt extinguishment
Unrealized loss on exchange rate
Unrealized (gain) loss on marketable securities
Gain on modification of operating lease
Change in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Laboratory supplies
Accounts payable
Accrued liabilities and other liabilities
Contract liabilities
NET CASH USED IN OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES
Adjustment related to Series A preferred prior period redemption payment
Purchase of property and equipment
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of common stock
Proceeds from convertible debt - related party
Proceeds from convertible debt
Proceeds of notes payable - related party
Repayment of notes payable - related party
Repayment of financed lease
Payments for preferred stock dividends
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET CHANGE IN CASH
CASH, beginning of the period
CASH, end of the period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for:
Interest
Income taxes
Non-cash investing and financing activities:
Series E preferred stock dividend
Series F preferred stock dividend
Initial amount of operating ROU asset and related liability
Relative fair value of warrant issued in connection with convertible notes - related party recorded as debt discount
Relative fair value of warrant issued in connection with convertible notes recorded as debt discount
Relative fair value of additional warrants issued in connection with modification of convertible notes - related party recorded as debt discount
Relative fair value of additional warrants issued in connection with modification of convertible notes recorded as debt discount
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND NATURE OF OPERATIONS
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Business Combination and Asset Acquisition [Abstract]
DISPOSAL OF SUBSIDIARIES AND RECAPITALIZATION
Investments, Debt and Equity Securities [Abstract]
MARKETABLE SECURITIES
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT
Debt Disclosure [Abstract]
DEBT
Lease Liabilities
LEASE LIABILITIES
Related Party Transactions [Abstract]
RELATED-PARTY TRANSACTIONS
Equity [Abstract]
STOCKHOLDERS’ DEFICIT
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Going Concern
Use of Estimates
Fair Value of Financial Instruments and Fair Value Measurements
Cash and Cash Equivalents
Prepaid Assets
Laboratory Supplies
Property and Equipment
Impairment of Long-Lived Assets
Stock-Based Compensation
Revenue Recognition and Contract Assets and Liabilities
Contract Liabilities
Cost of Revenue
Accounts Receivable and Allowance for Doubtful Accounts
Concentrations
Basic and Diluted Loss Per Share
Income Taxes
Related Parties
Leases
Recent Accounting Pronouncements
SCHEDULE OF CONTRACT LIABILITIES
SCHEDULE OF ANTI-DILUTIVE SHARES OUTSTANDING
SCHEDULE OF PROPERTY AND EQUIPMENT
SCHEDULE OF CONVERTIBLE NOTES PAYABLE
SCHEDULE OF FINANCIAL LEASE RIGHT-OF-USE ASSETS
SCHEDULE OF FINANCIAL LEASE LIABILITY
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS
SCHEDULE OF OPERATING RIGHT-OF-USE ASSET
SCHEDULE OF OPERATING LEASE LIABILITY
SCHEDULE OF FUTURE BASE LEASE PAYMENTS
SCHEDULE OF RELATED PARTIES TRANSACTION
SCHEDULE OF WARRANTS
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares issued
Percentage of voting Interests acquired
Common stock shares authorized
Conversion of stock shares converted
Sale of stock percentage of ownership after transaction
Gross proceeds from issuance of stock
Contract liabilities beginning balance
Billings and cash receipts on uncompleted contracts
Less: revenues recognized during the period
Total contract liabilities
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total antidilutive securities excluded from computation of earnings
Schedule of Product Information [Table]
Product Information [Line Items]
Net Income (Loss) Attributable to Parent
Net Cash Provided by (Used in) Operating Activities
Accumulated Deficit
Stockholders deficit
Working capital deficit
Property, Plant and Equipment, Useful Life
Cash FDIC insured amount
Revenue from Contract with Customer, Excluding Assessed Tax
Concentration Risk, Percentage
Accounts Receivable, after Allowance for Credit Loss, Current
Deferred Revenue
Other research and development expense
Uncertain tax portion
Income Tax Examination, Penalties and Interest Expense
Gain loss on dissolution of subsidiary
Schedule of Restructuring and Related Costs [Table]
Restructuring Cost and Reserve [Line Items]
Stock Issued During Period, Shares, Acquisitions
Stock Issued During Period, Value, Acquisitions
Marketable Securities, Unrealized Gain (Loss)
Marketable Securities
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Laboratory equipment
Estimated useful life in years
Furniture
Leasehold improvements
Computer equipment
Property and equipment, gross
Less accumulated depreciation
Property and equipment, net
Depreciation and amortization expense
Principal amount
Less: debt discount
Convertible notes payable, net
Principal amount – related party
Less: debt discount – related party
Convertible note payable - related party, net
Total convertible notes payable, net
Schedule of Short-Term Debt [Table]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount
Debt Instrument, Interest Rate, Stated Percentage
Debt Instrument, Interest Rate, Increase (Decrease)
Debt Instrument, Maturity Date
Proceeds from Related Party Debt
Debt Instrument, Convertible, Conversion Price
Debt Instrument, Interest Rate, Effective Percentage
Accrued interest paid
Notes Payable
Interest Payable
Convertible Notes Payable, Noncurrent
Notes Payable, Noncurrent
Fair value adjustment of warrants
Class of Warrant or Right, Exercise Price of Warrants or Rights
Debt Instrument, Fair Value Disclosure
Debt Instrument, Convertible, Beneficial Conversion Feature
Debt Instrument, Unamortized Discount
Amortization of Debt Discount (Premium)
Fair Value Adjustment of Warrants
Warrants and Rights Outstanding
Debt description
Proceeds from Convertible Debt
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Debt Conversion, Description
Debt Conversion, Converted Instrument, Amount
Due from Related Parties
Interest Payable, Current
Schedule Of Financial Lease Right-of-use Assets
Financing ROU assets
Less accumulated depreciation
Balance of Financing ROU assets
Schedule Of Financial Lease Liability
Financing lease payables for equipment
Total financing lease payables
Payments of financing lease liabilities
Total
Less: short term portion
Long term portion
2022
2023
2024
2025
Total minimum financing lease payments
Less: discount to fair value
Total financing lease payable at March 31, 2022
Operating office lease
Less accumulated reduction
Balance of Operating ROU asset
Operating office lease
Total operating lease liability
Reduction of operating lease liability
Total
Less: short term portion
Long term portion
2022
2023
2024
2025
2026
2027 and thereafter
Total minimum non-cancellable operating lease payments
Less: discount to fair value
Total operating lease liability at March 31, 2022
Payments for Rent
Lessee, Operating Lease, Term of Contract
Lease desription
Lease expiration date
Finance Lease, Principal Payments
Lessee, Finance Lease, Discount Rate
Depreciation expense financing ROU asset
Operating discount rates
Area of Land
Monthly rent, description
Operating Lease, Right-of-Use Asset
Operating Lease, Liability
Gain on lease modification
Lease cost
Base lease cost
Lease other expense
Convertible notes principal – related party
Discount on convertible notes - related party
Note payable principal – related party
Consulting fee – related party
Accounts payable – related party
Other receivable - related party
Total
Schedule of Related Party Transactions, by Related Party [Table]
Related Party Transaction [Line Items]
Consulting fees
Debt instrument, face amount
Proceeds from Notes Payable
Investments
Class of Warrant or Right, Outstanding
Advanced to related party
Accounts receivable related parties
Expense reimbursements
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of warrants, outstanding beginning balance
Weighted average exercise price, outstanding beginning balance
Weighted average remaining contractual term (years), beginning balance outstanding
Aggregate intrinsic value, beginning balance outstanding
Number of warrants, issued in connection with a convertible debt (see Note 6 and Note 8)
Weighted average exercise price, issued in connection with a convertible debt (see Note 6 and Note 8)
Weighted average remaining contractual term (years), issued in connection with a convertible debt
Aggregate intrinsic price, issued in connection with a convertible debt (see Note 6 and Note 8)
Number of warrants, issued in connection with a convertible debt - related party (see Note 6 and Note 8)
Weighted average exercise price, issued in connection with a convertible debt - related party (see Note 6 and Note 8)
Weighted average remaining contractual term (years), issued in connection with a convertible debt - related party (see Note 6 and Note 8)
Aggregate intrinsic value, issued in connection with a convertible debt - related party (see Note 6 and Note 8)
Number of warrants, outstanding ending balance
Weighted average exercise price, outstanding ending balance
Weighted average remaining contractual term (years), ending balance outstanding
Aggregate intrinsic value, ending balance outstanding
Number of warrants, exercisable
Weighted average exercise price, exercisable
Weighted average remaining contractual term (years), exercisable
Aggregate intrinsic value, exercisable
Schedule of Stock by Class [Table]
Class of Stock [Line Items]
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred stock converted
Common stock issued upon conversion
Preferred stock, shares authorized
Preferred stock, par value
Preferred stock, stated value
Debt interest rate
Preferred stock, conversion basis
Public offering, description
Conversion price
Sereis E preferred stock dividend
Dividends payable
Common stock issued for conversion
Common stock issued upon conversion
Issuance of common stock in connection with settlement of accounts payable
Issuance of common stock in connection with settlement of accounts payable shares
Share price
Sale of Stock, Number of Shares Issued in Transaction
Sale of Stock, Consideration Received on Transaction
Sale of Stock, Price Per Share
Common Stock, Shares, Outstanding
Common Stock, Shares Subscribed but Unissued
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Common Stock, Capital Shares Reserved for Future Issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Exercise price of warrants
Shares, Issued
Warrants issued
Warrants outstanding
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Annual base salary
Annual decretionary bonus percentage
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold
Accrued Salaries
Deferred compensation arrangements overall description
Compensation fees
Payments for Other Fees
Accrued consulting fees
Royalty Expense
Revenue, percentage
Advance Royalties
Non-refundable minimum annual royalty
Lease Expiration Date
Subscription payable
Stock Issued During Period, Shares, New Issues
Settlement of accounts payable
Common Stock, Shares Authorized
Accounts Payable, Current
Business Combination, Contingent Consideration, Liability
Accrued interest payable
Loss Contingency, Damages Awarded, Value
Loss Contingency, Damages Sought, Value
Subsequent Event [Table]
Subsequent Event [Line Items]
Conversion of Stock, Shares Converted
Warrants to purchase shares of common stock percentage
Proceeds from Issuance of Debt
Proceeds from a related party
Percentage of option price
Debt Instrument, Increase (Decrease), Net
Convertible debt related party noncurrent.
Subscription payable current.
Series c one preferred stock [Member]
Series c two preferred stock [Member]
Series d one preferred stock [Member]
Series d two preferred stock [Member]
Licensing fees.
Preferred stock series c one [Member]
Preferred stock series c two [Member]
Preferred stock series d one [Member]
Preferred stock series d two [Member]
Relative fair value of warrant issued in connection with convertible notes related party recorded as debt discount.
Relative fair value of warrant issued in connection with convertible notes recorded as debt discount.
Series E preferred stock dividend,
Series F preferred stock dividend.
Correction for rounding error.
Correction for rounding error, shares.
Issuance of common stock in connection with conversion of Series C1 preferred stock.
Issuance of common stock in connection with conversion of Series C1 preferred stock, shares.
Issuance of common stock in connection with conversion of Series C2 preferred stock.
Issuance of common stock in connection with conversion of Series C1 preferred stock, shares.
Issuance of common stock in connection with settlement of accounts payable.
Issuance of common stock in connection with settlement of accounts payable, shares.
Issuance of common stock in connection with subscription payable.
Relative fair value of additional warrants issued in connection with modification of convertible notes related party recorded as debt discount.
Relative fair value of additional warrants issued in connection with modification of convertible notes recorded as debt discount.
Adjustment related to Series A preferred prior period redemption payment.
Issuance of common stock in connection with subscription payable, shares.
First Lessor [Member]
Financing Agreement [Member]
Second Lessor [Member]
Third Lessor [Member]
Fourth Lessor [Member]
Fifth Lessor [Member]
Schedule of financing right of use assets table text block.
Depreciation expense financing ROU asset.
Schedule of financing lease liability table text block.
Financing lease payables for equipment.
Financing lease payables.
Payments of financing lease liabilities.
Lease Agreement [Member]
First Year [Member]
Second year [Member]
Third Year [Member]
Fourth Year [Member]
Fifth Year [Member]
Operating office lease.
Monthly rent, description.
Lease Amendment [Member]
Gains losses on modification of operating lease
Base lease cost.
Lease other expense.
Schedule of right of use assets table text block.
Less accumulated reduction.
Operating Office Lease Liability.
Total lease liabilities.
Reduction of operating lease liability.
After year four.
Adjustment related to Series A preferred prior period redemption payment.
Consulting fees.
Mr. Kucharchuk [Member]
Proceeds from convertible debt related party
Jeffrey Busch [Member]
Promissory Note Agreement [Member]
Repayment of financed lease
Cash Paid During Period For Interest [Abstract]
Preferred stock dividend one
Preferred stock dividend two
Investors [Member]
Convertible note [Member]
Securities purchase agreement [Member]
Warrant two [Member]
Asset Purchase Agreement [Member]
Avant [Member]
Convertible Note Principal Related Party.
Debt instrument unamortized discount related party.
Consulting fee due to related party.
Onc Bio Mune Sub Inc [Member]
First Investors [Member]
First Investors [Member]
Working capital deficit.
Prepaid asset policy text block.
Laboratory supplies policy text block.
Customer One [Member]
Customer Two [Member]
Customer Three [Member]
Deferred Revenue [Member]
Customer Four [Member]
Related parties policy text block
Gain loss on dissolution of subsidiary.
Amarantus BioScience Holdings, Inc. [Member]
Laboratory Equipment [Member]
Laboratory equipment.
Debt instrument face amount related party.
First tranche [Member]
Second Tranche [Member]
Third Tranche [Member]
Warrant one [Member]
Note One [Member]
Note Three [Member]
Note Two [Member]
Warrant Three [Member]
Note [Member]
Third Investor [Member]
Fisrt Investor [Member]
Related Party [Member]
Second investor [Member]
Second investors [Member]
First Investor [Member]
Second and Third Investor [Member]
Fourth Investor [Member]
Fifth Investor [Member]
Non cash lease cost.
Board of Directors [Member]
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Public offering description.
Two Consultants [Member]
Subscription Agreement [Member]
2011 Stock Option Plan [Member]
Fourth Investors [Member]
Warrants issued
Warrants outstanding
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.
Share Based Compensation Arrangement Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning.
Share based compensation arrangement by share based payment award non option equity instruments warrants issued in connection with issued in connection with a convertible debt.
Share based compensation arrangement by share based payment award non option equity instruments warrants issued in connection with expired in period weighted average granted.
Share based compensation arrangement by share based payment award non option equity instruments warrants issued in connection with issued in connection with a convertible debt weighted average remaining contratual term.
Share based compensation arrangement by share based payment award non-option equity instruments issued in connection with a convertible debt expired in period weighted average intrinsic value.
Share based compensation arrangement by share based payment award non option equity instruments warrants issued in connection with issued in connection with a convertible debt related party
Share based compensation arrangement by share based payment award non option equity instruments issued in connection with a convertible debt related party expired in period weighted average granted.
Share based compensation arrangement by share based payment convertible debt related party weighted average remaining contractual term debt
Share based compensation arrangement by share based payment award non-option equity instruments issued in connection with a convertible debt related party expired in period weighted average intrinsic value.
Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently outstanding or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Share based compensation arrangement by share based payment award non-options outstanding intrinsic value balance
The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan.
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan.
Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Sharebased compensation arrangement by sharebased payment award non options exercisable intrinsic value.
Annual decretionary bonus percentage.
Dr. Michael Ruxin [Member]
Ruxin Employment Agreement [Member]
2020 Equity Incentive Plan [Member]
Busch Employment Agreement [Member].
Thomas E Chilcott [Member]
Offer Letter [Member]
Thomas e chilcott three [Member]
Consultant [Member]
Scientific Advisory Board Service Agreement [Member]
Pathology Advisory Board Service Agreement [Member]
Consulting Agreement [Member]
Kucharchuk [Member]
Exclusive License Agreement [Member]
George Mason University [Member]
Revenue percentage.
Sublicense Royalty [Member]
License Agreement [Member]
National Institutes of Health [Member]
Non Refundable Minimum Annual Royalty.
Employee Incentive Stock Options [Member]
Settlement of accounts payable.
Settlement of accounts payable [Member]
Two Notes Payable [Member]
Percentage of warrants to purchase shares.
Percentage of option price.
Current portion of ccrued liabilities - related party..
Relative fair value of warrants issued in connection with convertible notes related party recorded as debt discount.
Relative fair value of warrants issued in connection with convertible notes recorded as debt discount.
Relative fair value of additional warrants issued in connection with modification of convertible notes related party recorded as debt discount.
Relative fair value of additional warrants issued in connection with modification of convertible notes recorded as debt discount.
Various Investors [Member]
Accrued interest paid.
Note Agreement [Member]
Conversion of Series C-1 Preferred Stock [Member]
Percentage of voting interest acquired.
Initial Amount Of Operating Rou Asset And Related Liability.
Contract Liabilities [Policy Text Block]
Billings and cash receipts on uncompleted contracts.
Cumulative revenues recognized.
First November 2021 [Member]
Second November 2021 [Member]
Third November 2021 [Member]
First January 2022 [Member]
Second January 2022 [Member]
First Investors [Member] [Default Label]
Assets, Current
Assets
Liabilities, Current
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Interest Expense
Foreign Currency Transaction Loss, before Tax
Nonoperating Income (Expense)
Dividends, Preferred Stock
Weighted Average Number of Shares Outstanding, Basic
Shares, Outstanding
Foreign Currency Transaction Gain (Loss), Unrealized
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Materials and Supplies
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Contract with Customer, Liability
Net Cash Provided by (Used in) Operating Activities
AdjustmentRelatedToPreferredSharesPriorPeriodRedemptionPayment
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Repayments of Related Party Debt
RepaymentOfFinancedLease
Payments of Ordinary Dividends, Preferred Stock and Preference Stock
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
PreferredStockDividendOne
PreferredStockDividendTwo
RelativeFairValueOfAdditionalWarrantIssuedInConnectionWithModificationOfConvertibleNotesRelatedPartyRecordedAsDebtDiscount
RelativeFairValueOfAdditionalWarrantIssuedInConnectionWithModificationOfConvertibleNotesRecordedAsDebtDiscount
CumulativeRevenuesRecognized
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
DebtInstrumentUnamortizedDiscountRelatedParty
Convertible Debt
Finance Lease, Right-of-Use Asset, Accumulated Amortization
FinancingLeasePayables
Finance Lease, Liability, to be Paid
Finance Lease, Liability, Undiscounted Excess Amount
OperatingOfficeLeaseLiability
OperatingLeaseLiabilities
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Lessee, Operating Lease, Liability, to be Paid, Year One
Lessee, Operating Lease, Liability, to be Paid, Year Two
Lessee, Operating Lease, Liability, to be Paid, Year Three
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Due from Other Related Parties, Current
Due to Related Parties, Current
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValueBalance
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
Aggregate intrinsic value, exercisable
Convertible Preferred Stock, Shares Issued upon Conversion